Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H27NO4 |
| Molecular Weight | 321.4113 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1(CCN(CCOCCO)CC1)C2=CC=CC=C2
InChI
InChIKey=KJTKYGFGPQSRRA-UHFFFAOYSA-N
InChI=1S/C18H27NO4/c1-2-23-17(21)18(16-6-4-3-5-7-16)8-10-19(11-9-18)12-14-22-15-13-20/h3-7,20H,2,8-15H2,1H3
| Molecular Formula | C18H27NO4 |
| Molecular Weight | 321.4113 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Pharmacological study of carbetidine, a new synthetic analgesic]. | 1958 May 1 |
|
| Studies on the respiratory and circulatory effects of carbetidine HCI used for supplementation of thiopentone sodium-nitrous oxide-oxygen anaesthesia. | 1959 Aug |
|
| [Brief note on a new synthetic analgesic: carbetidine hydrochloride]. | 1959 Jun |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:47:22 GMT 2023
by
admin
on
Sat Dec 16 16:47:22 GMT 2023
|
| Record UNII |
RHW35E1G7E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
||
|
DEA NO. |
9625
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID30196980
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
RHW35E1G7E
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
100000082114
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
726
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
ETOXERIDINE
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
DB01505
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
21 CFR 1308.11
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b)Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of paragraph (b)(34) only, the term isomer includes the optical and geometric isomers): | ||
|
C65599
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
SUB07343MIG
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
469-82-9
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104254
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
207-423-1
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY | |||
|
61122
Created by
admin on Sat Dec 16 16:47:22 GMT 2023 , Edited by admin on Sat Dec 16 16:47:22 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
